2051 - 2060 of 6422 Results
Title
Year
- RE-KINECT2020OPENTitle: RE-KINECTJournal Name: Journal of Clinical PsychopharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 40Issue #: 3Start Page: 259End Page: 268Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1097/jcp.0000000000001201Best OA location URL: https://escholarship.org/uc/item/4sc2z7gdCitation Count: 30
-
OPENTitle: Overcoming congressional inertia on obesity requires better literacy in obesity scienceJournal Name: ObesityPublisher: WileyVol: 30Issue #: 4Start Page: 799End Page: 801Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/oby.23405Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8957554Citation Count: 9
- Human Autopsy-Derived Scalp Fibroblast Biobanking for Age-Related Neurodegenerative Disease Research2020OPENTitle: Human Autopsy-Derived Scalp Fibroblast Biobanking for Age-Related Neurodegenerative Disease ResearchJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 11Start Page: 2383End Page: 2383Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9112383Best OA location URL: https://www.mdpi.com/2073-4409/9/11/2383/pdf?version=1604315178Citation Count: 3
-
OPENTitle: Brain Endothelial P-Glycoprotein Level Is Reduced in Parkinson’s Disease via a Vitamin D Receptor-Dependent PathwayJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 21Issue #: 22Start Page: 8538End Page: 8538Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms21228538Best OA location URL: https://www.mdpi.com/1422-0067/21/22/8538/pdf?version=1605248771Citation Count: 38
-
OPENTitle: Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-TauopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 4Start Page: 596End Page: 602Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00801Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9350900Citation Count: 46
-
OPENTitle: Health-Related Quality of Life Outcomes from Botulinum Toxin Treatment in SpasticityJournal Name: ToxinsPublisher: MDPI AGVol: 12Issue #: 5Start Page: 292End Page: 292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/toxins12050292Best OA location URL: https://www.mdpi.com/2072-6651/12/5/292/pdf?version=1590147891Citation Count: 8
-
OPENTitle: Telephone visit efficacy for Parkinson’s disease during the COVID-19 pandemicJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 5Issue #:Start Page: 100107End Page: 100107Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100107Best OA location URL: https://doi.org/10.1016/j.prdoa.2021.100107Citation Count: 4
-
OPENTitle: Objective screening for olfactory and gustatory dysfunction during the COVID‐19 pandemic: A prospective study in healthcare workers using self‐administered testingJournal Name: World Journal of Otorhinolaryngology - Head and Neck SurgeryPublisher: WileyVol: 8Issue #: 3Start Page: 249End Page: 256Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.wjorl.2021.02.001Best OA location URL: https://doi.org/10.1016/j.wjorl.2021.02.001Citation Count: 32
-
OPENTitle: AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutionsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 5Issue #:Start Page: 100115End Page: 100115Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100115Best OA location URL: https://doi.org/10.1016/j.prdoa.2021.100115Citation Count: 0
-
OPENTitle: Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel diseaseJournal Name: Pharmacogenetics and GenomicsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 32Issue #: 1Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/fpc.0000000000000445Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8578201Citation Count: 4